Skip to main content

Table 1 Effects of pharmacist intervention on physician prescribing, frequency of seclusion use, and medicine costs

From: Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study

  Pre-intervention in 2011 (n = 52) Post-intervention in 2012 (n = 52) p-value
Antipsychotic    
 dose (mg) 982.6 (200.0–2395.1) 857.6 (75.0–2418.6) p < 0.001
 No. of medicine(s) 2.0 (1.0–6.0) 2.0 (1.0–5.0) p = 0.025
Concurrent agent n (%)    
 anti-Parkinson 25 (48.1) 24 (46.2) p = 0.500
 benzodiazepine 42 (80.8) 38 (73.1) p = 0.243
 mood stabilizer 28 (53.8) 30 (57.5) p = 0.423
Seclusion room use n (%) 23 (44.2) 15 (28.8) p = 0.077
Cost (USD)    
 all medicine 10.33 (1.33–104.79) 8.76 (0.45–34.16) p = 0.045
 antipsychotic 8.04 (0.25–32.47) 6.48 (0.25–33.66) p = 0.016
 psychotropic 9.42 (0.25–64.12) 7.68 (0.25–34.05) p = 0.004
  1. Continuous variables indicate the median, and range in parentheses